Non-small cell lung cancer exhibits Transcript overexpression of Genes associated with homologous recombination and DNA replication pathways

Cancer Research

Volumn 69, Issue 8, 2009, Pages 3390-3396

  Saviozzi, Silvia ^a,b   Ceppi, Paolo ^a   Novello, Silvia ^a   Ghio, Paolo ^a   Iacono, Marco Lo ^a   Borasio, Piero ^a   Cambieri, Alberto ^a   Volante, Marco ^b   Papotti, Mauro ^b   Calogero, Raffaele A ^a   Scagliotti, Giorgio V ^a  

^a SAN LUIGI GONZAGA HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; DNA REPAIR; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; EXCISION REPAIR; FEMALE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TELOMERE; TOP3B GENE; TUMOR GENE; TYMS GENE; UBE2N GENE; UNG GENE; XPA GENE; XPC GENE; XRCC5 GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DNA REPLICATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECOMBINATION, GENETIC; TRANSCRIPTION, GENETIC;

EID: 65949124261     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2981     Document Type: Article

References (36)

1. Nakamura H, Saji H, Idiris A. et al. Chromosomal instability detected by fluorescence in situ hybridization in surgical specimens of non-small cell lung cancer is associated with poor survival. Clin. Cancer Res 2003; 9: 2294-9. (Pubitemid 36687655)
2. Markovic J, Stojsic J, Zunic S, Ruzdijic S, Tanic N. Genomic instability in patients with non-small-cell-lung-cancer assessed by the arbitrarily primed polymerase chain reaction. Cancer Invest 2008; 26: 262-8.
3. Zhou X, Kemp BL, Khuri FR. et al. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer. Clin. Cancer Res 2000; 6: 559-65. (Pubitemid 30111479)
4. Wei Q, Cheng L, Hong WK, Spitz MR, Reduced DNA repair capacity in lung cancer patients. Cancer Res 1996; 56: 4103-7. (Pubitemid 26304997)
5. Bosken CH, Wei Q, Amos CI, Spitz MR. An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer. J. Natl Cancer Inst 2002; 94: 1091-9.
6. Zeng-Rong N, Paterson J, Alpert E, Tsao MS, Viallet J, Alaoui-Jamali MA. Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy. Cancer Res 1995; 55: 4760-4.
7. Tsao MS, Aviel-Ronen S, Ding K. et al. Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer. J. Clin. Oncol 2007; 25: 5240-7. (Pubitemid 350232256)
8. Rosell R, Skrzypski M, Jassem E. et al. BRCA1: a novel prognostic factor in resected non-small-cell lung cancer, PLoS ONE 2007; 2: e1129.
9. Ceppi P, Volante M, Novello S. et al. ERCC1 and RRM1 gene expressions hut not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Ann Oncol 2006; 17: 1818-25.
10. Brooks KR, To K, joshi MB. et al. Measurement of chemoresistance markers in patients with stage III non-small cell lung cancer: a novel approach for patient selection. Ann Thorac Surg 2003; 76: 187-93. (Pubitemid 36819740)
11. Takenaka T, Yoshino I, Kouso H. et al. Combined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non-small cell lung cancer. Int J. Cancer 2007; 121: 895-900.
12. Weaver DA, Crawford EL, Warner KA, Elkhairi F, Khuder SA, Willey JC. ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines. Mol. Cancer 2005; 4: 18. (Pubitemid 41460841)
13. Bepler G, Kusmartseva I, Sharma S. et al, RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer, J. Clin. Oncol 2006; 24: 4731-7. (Pubitemid 46646245)
14. Takizawa M, Kawakami K, Ohata T. et al. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimi-dine dehydrogenase in human lung cancer. Oncol Rep 2006; 15: 1533-9.
15. Scagliotti GV, Fossati R, Torri V. et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J. Natl Cancer Inst 2003; 95: 1453-61. (Pubitemid 37279330)
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-ΔCΔ) } method. Methods 2001; 25: 402-8. (Pubitemid 34164012)
17. Vandesompele J, De Preter K, Pattyn F. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3: RESEARCH0034.
18. Saviozzi S, Cordero F, Lo Iacono M, Novello S, Scagliotti GV, Calogero RA. Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer, BMC Cancer 2006; 6: 200. (Pubitemid 44308956)
19. Popanda O, Schattenherg T, Phong CT. et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 2004; 25: 2433-41. (Pubitemid 39625184)
20. Gibson G, Weir B. The quantitative genetics of transcription. Trends Genet 2005; 21: 616-23. (Pubitemid 41429290)
21. Lin X, Gu J, Lu C, Spitz MR, Wu X. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin. Cancer Res 2006; 12: 5720-5. (Pubitemid 44629601)
22. Hu J, Sun L, Zhang C, Zhou X. Expression of telomenc repeat binding factor 1 in non-small cell lung cancer. J. Surg Oncol 2006; 93: 62-7. (Pubitemid 43038429)
23. Bartkova J, Horejsi Z, Koed K. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434: 864-70. (Pubitemid 40558993)
24. Gorgoulis VG, Vassiliou LV, Karakaidos P. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Mature 2005; 434: 907-13. (Pubitemid 40559004)
25. Nuciforo PG, Luise C, Capra M, Pelosi G, dAdda Di Fagagna P. Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression. Carcinogenesis 2007; 28: 2082-8. (Pubitemid 47543366)
26. Bartek J, Lukas J, Bartkova J. DNA damage response as an anti-cancer barrier: damage threshold and the concept of conditional haploinsufficiency'. Cell Cycle 2007; 6: 2344-7. (Pubitemid 350058685)
27. DAdda Di Fagagna F, Reaper PM, Clay-Farrace E. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003; 426: 194-8. (Pubitemid 37442589)
28. Dunham MA, Neumann AA, Fasching CL, Reddel RR. Telomere maintenance by recombination in human cells. Nat Genet 2000; 26: 447-50.
29. International Early Lung Cancer Action Program I, Henschke CI, Yip R, Miettinen OS. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA 2006; 296: 180-4. (Pubitemid 44050371)
30. Sun Z, Aubry MC, Deschamps C. et al. Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital-and 712 population-based cases. J. Thorac Cardiovasc Surg 2006; 131: 1014-20.
31. Sarasin A, Kauffmann A. Overexpression of DNA repair genes is associated with metastasis: a new hypothesis. Mutat Res 2008; 659: 49-55.
32. Kauffmann A, Rosselli F, Lazar V. et al. High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene 2008; 27: 565-73.
33. Wu YH, Tsai Chang JH, Cheng YW, Wu TC, Chen CY, Lee H. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hyper-methylation and contributes to p53 mutation in lung cancers. Oncogene 2007; 26: 4761-73. (Pubitemid 47093175)
34. Zhao GY, Sonoda E, Barber LJ. et al. A critical role for the ubiquitin-conjugating enzyme Ubc13 in initiating homologous recombination. Mol. Cell 2007; 25: 663-75. (Pubitemid 46341920)
35. Miyagawa K. Clinical relevance of the homologous recombination machinery in cancer therapy. Cancer Sci 2008; 99: 187-94.
36. Raz DJ, Ray MR, Kim JY. et al. A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma. Clin. Cancer Res 2008; 14: 5565-70.